Sort
130,381 grants matching “hiv”
Development Core
$990,291Mallory O Johnson · University Of California, San Francisco · P30 · FY2020 · MH
Developmental
$990,284R. Paul Johnson · Harvard University · P30 · FY2011 · AI
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$990,267Gail Geller · Johns Hopkins University · RM1 · FY2019 · HG
Clinical Core
$990,212Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2018 · AI
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
$990,189Jose Szapocznik · University Of Miami School Of Medicine · R01 · FY2023 · DA
Reducing Risk & Enhancing Protective Factors in Children
$990,133Richard F Catalano · University Of Washington · R01 · FY2007 · DA
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$990,110Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
$990,050Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2012 · HL
CASCADE Coordinating Center
$990,038Suzanne M. Siminski · Frontier Sci & Technology Rsch Fdn, Inc · U24 · FY2024 · CA
Retrovirus Evolution and Cancer
$990,000John M Coffin · Tufts University Boston · R35 · FY2016 · CA
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
$989,903Jae U Jung · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · CA
Durable HIV Vaccine Targeting Mucosal Epithelium
$989,873Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2022 · AI
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSMÂ
$989,833Rebecca Schnall · Columbia University Health Sciences · R01 · FY2024 · MD
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$989,774Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2023 · AI
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$989,774Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2022 · AI
WIHS VIROLOGIC RESISTANCE AND REBOUND STUDY
$989,684University Of California San Francisco · R01 · FY2000 · AI
COMMUNITY CONSORTIUM (CPCRA)
$989,647University Of California San Francisco · U01 · FY2004 · AI
HEU outcomes: population-evaluation and screening strategies (HOPE)
$989,559Grace C John-Stewart · University Of Washington · R33 · FY2024 · HD
San Diego Export: An University Community Partnership E*
$989,525University Of California San Diego · P60 · FY2004 · MD
Project 3
$989,330Alexander Marson · University Of California, San Francisco · U54 · FY2022 · AI
PEDIATRIC AIDS CLINICAL TRIAL UNIT
$989,191Univ Of Massachusetts Med Sch Worcester · U01 · FY2002 · AI
NEW ORLEANS ADOLESCENT MEDICINE TRIALS UNIT
$989,167Tulane University Of Louisiana · U01 · FY2005 · HD
Structure and Function of APOBEC3 Proteins
$989,129Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Case Proteomics Center for HIV/AIDS and Drug Abuse
$989,108Mark R Chance · Case Western Reserve University · P20 · FY2009 · DA
Rapid, Near-Tranfusion Test for Bacteria in Platelets Units
$989,098Andrew E. Levin · Immunetics, Inc. · R44 · FY2015 · HL